Predictive Value of Ki67 and P53 in Locally Advanced Rectal Cancer: Correlation with Thymidylate Synthase and Histopathological Tumor Regression After Neoadjuvant 5-FU-based Chemoradiotherapy

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2008 Feb 21

PMID 18286688

Citations 30

Authors

Christiane Jakob

Torsten Liersch

Wolfdietrich Meyer

Heinz Becker

Gustavo-B Baretton

Daniela-E Aust

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the predictive value of Ki67 and p53 and their correlation with thymidylate synthase (TS) gene expression in a rectal cancer patient cohort treated according to a standardized recommended neoadjuvant treatment regimen.

Methods: Formalin fixed, paraffin embedded pre-therapeutical tumor biopsies (n = 22) and post-therapeutical resection specimens (n = 40) from patients with rectal adenocarcinoma (clinical UICC stage II/III) receiving standardized neoadjuvant 5-fluorouracil (5-FU) based chemoradiotherapy were studied for Ki67 and p53 expression by immunohistochemistry and correlated with TS mRNA expression by quantitative TaqMan real-time PCR after laser microdissection. The results were compared with histopathological tumor regression according to a standardized semiquantitative score grading system.

Results: Responders (patients with high tumor regression) showed a significantly lower Ki67 expression than non-responders in the pre-therapeutical tumor biopsies (81.2% vs 16.7%; P < 0.05) as well as in the post-therapeutical resection specimens (75.8% vs 14.3%; P < 0.01). High TS mRNA expression was significantly correlated with a high Ki67 index and low TS mRNA expression was significantly correlated with a low Ki67 index in the pre-therapeutical tumor biopsies (corr. coef. = 0.46; P < 0.01) as well as in the post-therapeutical resection specimens (corr. coef. = 0.40; P < 0.05). No significant association was found between p53 and TS mRNA expression or tumor regression.

Conclusion: Ki67 has, like TS, predictive value in rectal cancer patients after neoadjuvant 5-FU based chemoradiotherapy. The close correlation between Ki67 and TS indicates that TS is involved in active cell cycle processes.

Citing Articles

Advanced diffusion-weighted imaging biomarkers for non-invasive assessment of tumor microenvironment in rectal cancer: restricted spectrum imaging.

Yuan J, Sun Y, Liu K, Han G, Wang Z, Liu M Abdom Radiol (NY). 2025; .

PMID: 39932551 DOI: 10.1007/s00261-025-04819-w.

Molecular prognostic factors in colorectal cancer: 5-year follow-up.

Ciobanu A, Pirvu D, Marginean C, Dijmarescu A, Munoz-Groza A, Mesina C Rom J Morphol Embryol. 2023; 64(1):65-71.

PMID: 37128793 PMC: 10257784. DOI: 10.47162/RJME.64.1.08.

A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

Dalle Fratte C, Mezzalira S, Polesel J, De Mattia E, Palumbo A, Buonadonna A Oncol Res. 2021; 28(9):847-855.

PMID: 34108073 PMC: 8790137. DOI: 10.3727/096504021X16232280278813.

Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling.

Izzotti A, Ceccaroli C, Geretto M, Ruggieri F, Schenone S, Di Maria E Cancers (Basel). 2020; 12(6).

PMID: 32580435 PMC: 7352797. DOI: 10.3390/cancers12061652.

Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.

Koulis C, Yap R, Engel R, Jarde T, Wilkins S, Solon G Cancers (Basel). 2020; 12(4).

PMID: 32231042 PMC: 7225926. DOI: 10.3390/cancers12040812.

References

Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351(17):1731-40. DOI: 10.1056/NEJMoa040694. View

Minsky B, Cohen A, Kemeny N, Enker W, Kelsen D, Reichman B . Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol. 1992; 10(1):79-84. DOI: 10.1200/JCO.1992.10.1.79. View

Grem J, Danenberg K, Behan K, Parr A, Young L, Danenberg P . Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen. Clin Cancer Res. 2001; 7(4):999-1009. View

Meyers M, Wagner M, Hwang H, Kinsella T, Boothman D . Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res. 2001; 61(13):5193-201. View

Watanabe T, Wu T, Catalano P, Ueki T, Satriano R, Haller D . Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001; 344(16):1196-206. PMC: 3584633. DOI: 10.1056/NEJM200104193441603. View

Kornmann M, Danenberg K, Arber N, Beger H, Danenberg P, Korc M . Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res. 1999; 59(14):3505-11. View

Wang W, McLeod H, Cassidy J . Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer. 2003; 104(4):504-11. DOI: 10.1002/ijc.10972. View

Dworak O, Keilholz L, Hoffmann A . Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997; 12(1):19-23. DOI: 10.1007/s003840050072. View

HEIDELBERGER C, Chaudhuri N, DANNEBERG P, Mooren D, GRIESBACH L, DUSCHINSKY R . Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957; 179(4561):663-6. DOI: 10.1038/179663a0. View

10.

Lopez-Crapez E, Bibeau F, Thezenas S, Ychou M, Simony-Lafontaine J, Thirion A . p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer. 2005; 92(12):2114-21. PMC: 2361816. DOI: 10.1038/sj.bjc.6602622. View

11.

Popat S, Matakidou A, Houlston R . Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2004; 22(3):529-36. DOI: 10.1200/JCO.2004.05.064. View

12.

Ahnen D, Feigl P, Quan G, Lovato L, Bunn Jr P, Stemmerman G . Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res. 1998; 58(6):1149-58. View

13.

Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R . p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res. 1997; 3(8):1405-11. View

14.

Smith F, Reynolds J, Miller N, Stephens R, Kennedy M . Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol. 2005; 32(1):55-64. DOI: 10.1016/j.ejso.2005.09.010. View

15.

Witzig T, Loprinzi C, Gonchoroff N, Reiman H, Cha S, Wieand H . DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer. 1991; 68(4):879-88. DOI: 10.1002/1097-0142(19910815)68:4<879::aid-cncr2820680434>3.0.co;2-4. View

16.

Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L . The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst. 1996; 88(3-4):173-82. DOI: 10.1093/jnci/88.3-4.173. View

17.

Zeng Z, Sarkis A, Zhang Z, Klimstra D, Charytonowicz E, Guillem J . p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. J Clin Oncol. 1994; 12(10):2043-50. DOI: 10.1200/JCO.1994.12.10.2043. View

18.

Jakob C, Aust D, Meyer W, Baretton G, Schwabe W, Hausler P . Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. J Pathol. 2004; 204(5):562-8. DOI: 10.1002/path.1663. View

19.

Jakob C, Liersch T, Meyer W, Baretton G, Hausler P, Schwabe W . Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant.... Am J Surg Pathol. 2005; 29(10):1304-9. DOI: 10.1097/01.pas.0000170346.55304.88. View

20.

Pestalozzi B, McGinn C, Kinsella T, Drake J, Glennon M, Allegra C . Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells. Br J Cancer. 1995; 71(6):1151-7. PMC: 2033861. DOI: 10.1038/bjc.1995.225. View